Literature DB >> 9067756

Three germline mutations in the TP53 gene.

R S Cornelis1, M van Vliet, M J van de Vijver, H F Vasen, P A Voute, B Top, P M Khan, P Devilee, C J Cornelisse.   

Abstract

Three germline mutations in the TP53 tumor-suppressor gene are reported, two of which are not reported previously. A missense mutation at codon 265 of TP53 was found in three patients of a family that complied with the definition of the Li-Fraumeni syndrome. A nonsense mutation in codon 306 was found in a woman who had had a rhabdomyosarcoma at age 4 and a subsequent breast cancer at age 22. She was part of a Li-Fraumeni-like family, but the parental origin of the mutation could not be traced. Finally, while screening for somatic alterations in TP53 in a series of 141 sporadic breast tumors, we detected a constitutional missense mutation in codon 235 in a woman diagnosed with breast cancer at age 26 and a recurrence 4 years later. The recurrence, but not the primary tumor, showed an additional missense mutation at codon 245 as well as loss of the wild-type allele. This suggests that the 245 mutation was particularly important for tumor progression and that there might exist heterogeneity in terms of cancer predisposition potential among the various germline TP53 mutations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067756     DOI: 10.1002/(SICI)1098-1004(1997)9:2<157::AID-HUMU8>3.0.CO;2-6

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

1.  Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.

Authors:  Matthew B Yurgelun; Serena Masciari; Victoria A Joshi; Rowena C Mercado; Noralane M Lindor; Steven Gallinger; John L Hopper; Mark A Jenkins; Daniel D Buchanan; Polly A Newcomb; John D Potter; Robert W Haile; Raju Kucherlapati; Sapna Syngal
Journal:  JAMA Oncol       Date:  2015-05       Impact factor: 31.777

2.  Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.

Authors:  Liselotte P van Hest; Mariëlle W G Ruijs; Anja Wagner; Conny A van der Meer; Senno Verhoef; Laura J van't Veer; Hanne Meijers-Heijboer
Journal:  Fam Cancer       Date:  2007-02-23       Impact factor: 2.375

3.  Li-Fraumeni Syndrome: A Rare Genetic Disorder.

Authors:  Faria Tazin; Harendra Kumar; Muhammad A Israr; Deborah Omoleye; Vern Orlang
Journal:  Cureus       Date:  2022-09-16

4.  Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.

Authors:  Simone Hettmer; Natasha M Archer; Gino R Somers; Ana Novokmet; Amy J Wagers; Lisa Diller; Carlos Rodriguez-Galindo; Lisa A Teot; David Malkin
Journal:  Cancer       Date:  2013-12-30       Impact factor: 6.860

5.  Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families.

Authors:  Xuan Liu; Hans-Peter Sinn; Hans Ulrich Ulmer; Rodney J Scott; Ute Hamann
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.